Bank of New York Mellon
RYZB

Bank of New York Mellon’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Bank of New York Mellon’s Portfolio RYZB Stock Details RYZB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-64,609
Closed -$4.02M – 4373
2023
Q4 		$4.02M Buy
+64,609
New +$1.61M ﹤0.01% 2478

Bank of New York Mellon's RYZB Position: Q1 2024 in Review

Bank of New York Mellon sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 64,609 shares — an estimated $4.02M sold.

Bank of New York Mellon first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $4.02M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • Bank of New York Mellon reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 64,609 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $4.02M.
  • Bank of New York Mellon first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Bank of New York Mellon's RayzeBio, Inc. Common Stock position peaked at $4.02M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.